Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP373151.RAAUr2mLR37JaKiGQuiS9F16iGkEErK9aeBVMeMIUbVKM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP373151.RAAUr2mLR37JaKiGQuiS9F16iGkEErK9aeBVMeMIUbVKM130_assertion type Assertion NP373151.RAAUr2mLR37JaKiGQuiS9F16iGkEErK9aeBVMeMIUbVKM130_head.
- NP373151.RAAUr2mLR37JaKiGQuiS9F16iGkEErK9aeBVMeMIUbVKM130_assertion description "[We suggest that the 20210 G/A prothrombin gene mutation be measured in all women on ERT or before beginning ERT to identify those heterozygous for the thrombophilic prothrombin gene mutation (4%) in whom ERT is contraindicated because of increased risk for ATCVD and thromboembolism, and a second, much larger group of women without the 20210 G/A prothrombin gene mutation (96%) in whom ERT may possibly reduce risk for ATCVD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373151.RAAUr2mLR37JaKiGQuiS9F16iGkEErK9aeBVMeMIUbVKM130_provenance.
- NP373151.RAAUr2mLR37JaKiGQuiS9F16iGkEErK9aeBVMeMIUbVKM130_assertion evidence source_evidence_literature NP373151.RAAUr2mLR37JaKiGQuiS9F16iGkEErK9aeBVMeMIUbVKM130_provenance.
- NP373151.RAAUr2mLR37JaKiGQuiS9F16iGkEErK9aeBVMeMIUbVKM130_assertion SIO_000772 11230792 NP373151.RAAUr2mLR37JaKiGQuiS9F16iGkEErK9aeBVMeMIUbVKM130_provenance.
- NP373151.RAAUr2mLR37JaKiGQuiS9F16iGkEErK9aeBVMeMIUbVKM130_assertion wasDerivedFrom befree-20150227 NP373151.RAAUr2mLR37JaKiGQuiS9F16iGkEErK9aeBVMeMIUbVKM130_provenance.
- NP373151.RAAUr2mLR37JaKiGQuiS9F16iGkEErK9aeBVMeMIUbVKM130_assertion wasGeneratedBy ECO_0000203 NP373151.RAAUr2mLR37JaKiGQuiS9F16iGkEErK9aeBVMeMIUbVKM130_provenance.